NATCO Pharma Limited (NATCOPHARM.NS) NSE

886.20

+14.4(+1.65%)

Updated at January 14 02:44PM

Currency In INR

Valuation

Market Cap144.18B
Enterprise Value125.22B
P/E Ratio10.3
PEG Ratio-1.1
Price/Sales Ratio3.61
Price/Book Ratio1.83
Enterprise/Revenue3.65
Enterprise/EBITDA8.95

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.35
Operating Margin0.45

Management Effectiveness

Return On Assets0.15
Return On Equity0.2

Income Statement

Revenue44.32B
Revenue/Share245.08
Gross Profit37.05B
EBITDA21.44B
Net Income18.85B
Diluted EPS105.26

Balance Sheet

Total Cash40.77B
Total Cash/Share227.59
Total Debt2.61B
Total Debt/Equity0.03
Current Ratio4.1
Book Value Per Share483.13

Price History

52-Week Change-29.6
52-Week High1,341
52-Week Low726.8
Moving Average 50 Days882.61
Moving Average 200 Days876.98

Statistics

Average Volume1.49M
Shares Outstanding179.11M
% Held by Institutions0.05

Dividend And Splits

Trailing Annual Dividend Rate5
Trailing Annual Dividend Yield0.57
Payout Ratio0
Last Split Factor5:1
Last Split DateNovember 26, 2015